Cookies help us deliver our services. By using our services, you agree to our use of cookies.

Michael Kauffman

Active: 2018

Michael Kauffman, MD, PhD, is the CEO of Karyopharm Therapeutics Inc. (KPTI), which was founded by his wife Sharon Shacham, PhD, in 2018. KPTI is developing novel oral anti-cancer drugs for multiple tumors, and its first product, selinexor, is in late-stage clinical testing in blood cancers. (based on info from 2018 )


Jun 29, 2018
Jun 29, 2018